Akums Drugs Files FY26 Business Responsibility & Sustainability Report

Akums Drugs and Pharmaceuticals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, along with an Independent Assurance Statement from BDO India Services Private Limited. The report, which is part of the Integrated Annual Report, details the company's business activities, including manufacturing of pharma products and allied services, which accounted for 90% of its turnover. Key activities include CDMO services (79.95%), API manufacturing (4.23%), Domestic Branded Formulations (10.25%), International Branded Formulations (3.29%), and Trade Generics (2.29%). The company operates 14 plants and 5 offices nationally, serving a diverse customer base including pharmaceutical and FMCG companies, and healthcare providers, with exports contributing 4.4% to turnover.